Sotrovimab - activities

Covid: Sotrovimab, an antibody-based therapy developed by GSK, approved in the United Kingdom

To fight against Covid and especially the Omicron variant, the UK regulator announced this Thursday December 2 they have approved Sotrovimab, a therapy developed by the GSK laboratories based on monoclonal antibodies based on the “natural antibodies humans already make”. A therapy the European Union already ordered this past June.

Coronavirus: The European Union ordered a new antibody therapy

This Wednesday July 28, the European Union announced they have secured a deal for a new experimental coronavirus therapy, Sotrovimab, developed by UK laboratory GSK. A promising monoclonal antibody therapy.